(Q51912802)

English

Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of A

scientific article published on 12 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

breast carcinoma

1 reference

based on heuristic

inferred from title

clinical oncology

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

M Dietel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Höfler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Kreipe

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Moch

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A Dankof

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Kölble

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

G Kristiansen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

12 June 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Virchows Archiv

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

451

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

19-25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562074%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

https://scigraph.springernature.com/pub.10.1007/s00428-007-0424-5

0 references

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1007%2FS00428-007-0424-5

21 January 2018

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of HER-2/neu Status in Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of observer agreement

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of HER2 testing: results of an international proficiency-testing ring study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Best Practice No 176: Updated recommendations for HER2 testing in the UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue pretreatment with formic acid might lower HercepTest scores in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17562074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51912802&oldid=1531907136"